Premium
P4‐376: A phase 3 multicenter trial of tarenflurbil in subjects with mild dementia of the Alzheimer's type (Act‐Earli‐AD): Rationale and methodology
Author(s) -
Jackson Mary,
Hendrix Suzanne,
Zavitz Kenton,
Green Robert C.,
Schneider Lon S.,
Swabb Edward
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2446
Subject(s) - memantine , medicine , placebo , randomization , dementia , randomized controlled trial , adverse effect , disease , pathology , alternative medicine